Acute Pancreatitis Clinical Trials

24 recruiting

Acute Pancreatitis Trials at a Glance

47 actively recruiting trials for acute pancreatitis are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Pittsburgh, Shanghai, and Baltimore. Lead sponsors running acute pancreatitis studies include Changhai Hospital, Peking Union Medical College Hospital, and Air Force Military Medical University, China.

Browse acute pancreatitis trials by phase

Treatments under study

About Acute Pancreatitis Clinical Trials

Looking for clinical trials for Acute Pancreatitis? There are currently 24 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Acute Pancreatitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Acute Pancreatitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 47 trials

Recruiting
Phase 4

Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis

Post-ERCP Acute Pancreatitis
University of Calgary505 enrolled1 locationNCT06260878
Recruiting
Phase 1Phase 2

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Acute Pancreatitis
St. Jude Children's Research Hospital42 enrolled2 locationsNCT04195347
Recruiting
Phase 4

Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis

Chronic PancreatitisExocrine Pancreatic InsufficiencyRecurrent Acute Pancreatitis
Anna Evans Phillips80 enrolled2 locationsNCT07418593
Recruiting
Not Applicable

FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis

Acute Pancreatitis
Changhai Hospital150 enrolled12 locationsNCT07464392
Recruiting

Prospective Registry Of Therapeutic EndoscopiC ulTrasound

Chronic PancreatitisGastric Outlet ObstructionAcute Pancreatic Fluid Collection+3 more
Paolo Giorgio Arcidiacono, MD510 enrolled1 locationNCT04813055
Recruiting
Phase 2

A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

Acute Pancreatitis
Panafina, Inc.36 enrolled15 locationsNCT06080789
Recruiting

Bowel Sound in Predicting the Severity of Acute Pancreatitis: Protocol of a Prospective, Multi-center Study

Acute Pancreatitis (AP)Severe Acute Pancreatitis
Peking Union Medical College Hospital352 enrolled1 locationNCT06867120
Recruiting

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Pancreatic CancerPancreatic AdenocarcinomaPancreatic Neuroendocrine Carcinoma+5 more
Mayo Clinic20,000 enrolled3 locationsNCT00830557
Recruiting

Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disorders

Acute Pancreatitis (AP)Thrombotic Disorders
RenJi Hospital10 enrolled1 locationNCT07450898
Recruiting

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Chronic PancreatitisExocrine Pancreas CarcinomaRecurrent Acute Pancreatitis
M.D. Anderson Cancer Center1,600 enrolled26 locationsNCT06651580
Recruiting
Phase 2

Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis

Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis
Fujian Shengdi Pharmaceutical Co., Ltd.108 enrolled1 locationNCT07308392
Recruiting
Not Applicable

Necrosectomy With Cryotechnology for Accelerated Removal

Acute PancreatitisPancreatic NecrosisAcute Pancreatic Necrosis+3 more
Christopher C. Thompson, MD, MSc20 enrolled1 locationNCT06553651
Recruiting
Phase 1Phase 2

Soy Tomato Juice to Improve Outcomes in Pancreatitis

Chronic PancreatitisRecurrent Acute Pancreatitis
Ohio State University35 enrolled1 locationNCT07447687
Recruiting
Early Phase 1

Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

Chronic PancreatitisRecurrent Acute Pancreatitis
Cedars-Sinai Medical Center90 enrolled5 locationsNCT05771675
Recruiting

AI-Powered Precision Decision-Making for Pancreatic Diseases

Pancreatic CancerPancreatic Neuroendocrine TumorChronic Pancreatitis+4 more
Changhai Hospital2,000 enrolled1 locationNCT07439757
Recruiting

Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

Acute Pancreatitis
Milton S. Hershey Medical Center800 enrolled13 locationsNCT06401577
Recruiting
Not Applicable

Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis

Hypertriglyceridemia Induced Acute Pancreatitis
General Hospital of Shenyang Military Region40 enrolled1 locationNCT07388420
Recruiting

Incidence of Splanchnic Venous Thrombosis in Acute Pancreatitis and it's Correlation With Severity of Pancreatitis

Acute Pancreatitis
Asian Institute of Gastroenterology, India500 enrolled1 locationNCT07322978
Recruiting
Phase 3

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

Post-ERCP Acute Pancreatitis
Johns Hopkins University4,874 enrolled5 locationsNCT05252754
Recruiting
Not Applicable

Rectal NSAIDs With/Without PD Stent for PEP Prevention

Post-ERCP Acute PancreatitisNon-steroid Anti-inflammatory DrugsPancreatic Duct Stent Placement
Air Force Military Medical University, China1,278 enrolled15 locationsNCT07117318